Page 117 - Case Lab Case Analysis

Generic options captured in the Athenahealth data included Mylan's own
EpiPen alternative.

Dec 2016 Mylan's own EpiPen alternative 50% lower price
launched
Dec 2016 CVS stock the generic version of Adrenaclick, at $110
equivalent
Feb 2017 Kaleo's AUVI-Q re-released

At the end of 2016, EpiPen alternatives made up only 5.3 percent of
prescriptions for epinephrine auto-injectors. By the last full week of
February, that figure had grown to 28.9 percent.

In January 2017, Cigna (health insurance and services) started covering
only the generic options to EpiPen.

Moreover,
“Patients and providers might be reaching for the alternatives and
generics that have recently hit the shelves, as the industry responds
to widespread demand.”

Source: https://insight.athenahealth.com/prescriptions-jump-epipen-alternatives

Source: https://insight.athenahealth.com/prescriptions-jump-epipen-alternatives